We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Vaccine Boostrix Gets Boost From FDA Older Adults Approval
GSK Vaccine Boostrix Gets Boost From FDA Older Adults Approval
July 15, 2011
The FDA is expanding the use of GlaxoSmithKline’s (GSK) diphtheria, pertussis (whooping cough) and tetanus vaccine Boostrix to include patients age 65 and older, making it the first single-dose vaccine approved to prevent all three diseases in this population.